Effects of Roflumilast in Hospitalized Chronic Obstructive Pulmonary Disease( COPD) on Mortality and Re-hospitalization

NCT01973998 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

COPD

Interventions

DRUG: Roflumilast
DRUG: Placebo

Sponsor

Temple University

Collaborators

[object Object]